@article{BellutRaimondiHaarmannetal.2022,
  author    = {Bellut, Maximilian and Raimondi, Anthony T. and Haarmann, Axel and Zimmermann, Lena and Stoll, Guido and Schuhmann, Michael K.},
  title     = {NLRP3 inhibition reduces rt-PA induced endothelial dysfunction under ischemic conditions},
  series = {Biomedicines},
  volume    = {10},
  journal   = {Biomedicines},
  number    = {4},
  issn      = {2227-9059},
  doi       = {10.3390/biomedicines10040762},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-267261},
  year      = {2022},
  abstract  = {Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is a mainstay of acute ischemic stroke treatment but is associated with bleeding complications, especially after prolonged large vessel occlusion. Recently, inhibition of the NLRP3 inflammasome led to preserved blood-brain barrier (BBB) integrity in experimental stroke in vivo. To further address the potential of NLRP3 inflammasome inhibition as adjunct stroke treatment we used immortalized brain derived endothelial cells (bEnd5) as an in vitro model of the BBB. We treated bEnd5 with rt-PA in combination with the NLRP3 specific inhibitor MCC950 or vehicle under normoxic as well as ischemic (OGD) conditions. We found that rt-PA exerted a cytotoxic effect on bEnd5 cells under OGD confirming that rt-PA is harmful to the BBB. This detrimental effect could be significantly reduced by MCC950 treatment. Moreover, under ischemic conditions, the Cell Index — a sensible indicator for a patent BBB — and the protein expression of Zonula occludens 1 stabilized after MCC950 treatment. At the same time, the extent of endothelial cell death and NLRP3 expression decreased. In conclusion, NLRP3 inhibition can protect the BBB from rt-PA-induced damage and thereby potentially increase the narrow time window for safe thrombolysis in stroke.},
  language  = {en}
}
@phdthesis{Mickler2015,
  author    = {Mickler, Johannes},
  title     = {Ver{\"a}nderungen von mesenchymalen Stammzellen des Fettgewebes auf DNA- und Chromatidebene w{\"a}hrend ihrer Expansion in vitro},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-122291},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {Stammzellbasierte Therapieverfahren versprechen neue L{\"o}sungen f{\"u}r bisher nur unzureichend behandelbare Erkrankungen. In der Hals-, Nasen- und Ohrenheilkunde ist die Herstellung von Knorpel im Rahmen des Tissue Engineering von besonderem Interesse. Die mesenchymalen Stammzellen des Fettgewebes (ASC) stellen eine vielversprechende Zellpopulation als Ausgangspunkt f{\"u}r die Erzeugung von Gewebe dar. Auf Grund der hohen Zahl an Zellteilungen, oxidativem und mechanischem Stress sowie enzymatischer Verdauung steigt im Rahmen der in vitro Expansion das Risiko f{\"u}r DNA-Sch{\"a}den. Diese k{\"o}nnen wiederum der Ausgangspunkt f{\"u}r die maligne Transformation einer Zelle sein. Ziel unserer Studie war es, zu zeigen, ob die Expansion und mehrfache Passagierung zu einer zunehmenden genetischen Instabilit{\"a}t der ASC f{\"u}hrt. Es wurden frische ASC aus Liposuktionsaspirat von 8 verschiedenen Patienten isoliert. Mit ASC der Passagen 1, 2, 3, 5 und 10 wurde zur Detektion von Sch{\"a}den auf DNA-Ebene jeweils eine alkalische Einzelzellgelelektrophorese(Comet Assay) und ein Mikrokerntest durchgef{\"u}hrt. Zur Erfassung von Sch{\"a}den auf Chromatidebene erfolgte dar{\"u}ber hinaus mit Zellen der selben Passage ein Chromosomenaberrationstest. Mit dem Comet Assay und dem Mikrokerntest konnte keine signifikante Progression der genetischen Instabilit{\"a}t mit zunehmender Passage nachgewiesen werden. Beim Chromosomenaberrationstest zeigte sich im Friedman-Test eine signifikante Zunahme an strukturellen Chromosomenaberrationen mit steigender Passage. Der Wilcoxon-Test hingegen erbrachte kein signifikantes Ergebnis. Die im Rahmen dieser Arbeit gewonnen Daten zeigen, dass eine zunehmende genetische Instabilit{\"a}t der ASC mit zunehmender Dauer der Expansion und steigender Passage nicht vollst{\"a}ndig ausgeschlossen werden kann. Aus diesem Grund sollten vor einer Transplantation regelhaft Untersuchungen wie beispielsweise ein Chromosomenaberrationstest oder ein Screening auf typische malignit{\"a}tsf{\"o}rdernde Mutationen erfolgen.},
  subject      = {Stammzelle},
  language  = {de}
}
@article{RadeloffWeissHagenetal.2021,
  author    = {Radeloff, Katrin and Weiss, Dorothee and Hagen, Rudolf and Kleinsasser, Norbert and Radeloff, Andreas},
  title     = {Differentiation behaviour of adipose-derived stromal cells (ASCs) seeded on polyurethane-fibrin scaffolds in vitro and in vivo},
  series = {Biomedicines},
  volume    = {9},
  journal   = {Biomedicines},
  number    = {8},
  issn      = {2227-9059},
  doi       = {10.3390/biomedicines9080982},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-245030},
  year      = {2021},
  abstract  = {Adipose-derived stromal cells (ASCs) are a promising cell source for tissue engineering and regenerative medicine approaches for cartilage replacement. For chondrogenic differentiation, human (h)ASCs were seeded on three-dimensional polyurethane (PU) fibrin composites and induced with a chondrogenic differentiation medium containing TGF-ß3, BMP-6, and IGF-1 in various combinations. In addition, in vitro predifferentiated cell-seeded constructs were implanted into auricular cartilage defects of New Zealand White Rabbits for 4 and 12 weeks. Histological, immunohistochemical, and RT-PCR analyses were performed on the constructs maintained in vitro to determine extracellular matrix (ECM) deposition and expression of specific cartilage markers. Chondrogenic differentiated constructs showed a uniform distribution of cells and ECM proteins. RT-PCR showed increased gene expression of collagen II, collagen X, and aggrecan and nearly stable expression of SOX-9 and collagen I. Rabbit (r)ASC-seeded PU-fibrin composites implanted in ear cartilage defects of New Zealand White Rabbits showed deposition of ECM with structures resembling cartilage lacunae by Alcian blue staining. However, extracellular calcium deposition became detectable over the course of 12 weeks. RT-PCR showed evidence of endochondral ossification during the time course with the expression of specific marker genes (collagen X and RUNX-2). In conclusion, hASCs show chondrogenic differentiation capacity in vitro with the expression of specific marker genes and deposition of cartilage-specific ECM proteins. After implantation of predifferentiated rASC-seeded PU-fibrin scaffolds into a cartilage defect, the constructs undergo the route of endochondral ossification.},
  language  = {en}
}